Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/pharmacodynamic population studies
- 23 January 2004
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 23 (4) , 531-544
- https://doi.org/10.1002/sim.1619
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The impact of compliance in pharmacokinetic studiesStatistical Methods in Medical Research, 1999
- Comparing compliance patterns between randomized treatmentsControlled Clinical Trials, 1997
- Optimal design in random-effects regression modelsBiometrika, 1997
- The Electronic Medication Event MonitorClinical Pharmacokinetics, 1997
- Role of Patient Compliance in Clinical PharmacokineticsClinical Pharmacokinetics, 1994
- Designs for population pharmacodynamics: Value of pharmacokinetic data and population analysisJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Compliance as an Explanatory Variable in Clinical TrialsJournal of the American Statistical Association, 1991
- Concentration-effect analysis of antihypertensive drug responses.Hypertension, 1990
- PharmacokineticsPublished by Taylor & Francis ,1982
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981